Disclaimer

Disclaimer: The information provided below on the Tylenol Autism Lawsuit serves educational purposes only. Ethen Ostroff Law is no longer accepting new cases concerning the Tylenol Autism Lawsuit as discussed here. This content offers general insights into legal matters and is not a replacement for professional legal advice. Individuals should consult qualified legal professionals for advice tailored to their specific situations.

Tylenol Autism Lawsuit Updates (2025)

For years, doctors and mothers alike saw Tylenol as the safest choice for managing pain during pregnancy. It was a comfort, a default. But now, a wave of new research is calling that long-held assumption into question, suggesting a link between regular prenatal use and a higher risk of a child developing autism (ASD) or ADHD.

In search of answers and support for their children’s future, a great many of these parents have become part of the growing Tylenol autism lawsuit and related ADHD claims. The main group of federal lawsuits is currently on hold. They were dismissed back in 2024 after a judge concluded the scientific evidence presented wasn’t sufficiently strong to proceed. Families have appealed that decision. All eyes are now on the Second Circuit Court of Appeals to decide if these lawsuits get a second chance.

State-level cases are still actively moving forward in various courts. And in a significant shift, the FDA has begun the process of updating Tylenol’s labeling to include warnings about these potential risks.

In this article, we’ll go through the Tylenol autism lawsuit, explain why parents are filing, who might qualify, and what the latest developments in 2025 mean for families thinking about a claim.

Get Your Free Case Review

Find out if you qualify for compensation and learn your next steps – no cost, no obligation, just expert legal guidance.

Disclaimer: By submitting the form above and checking the consent box, you agree to our conditions and privacy policy and permit Ethen Ostroff Law to contact you via text messages, phone calls. Standard message rates may apply.


Get Your Free Case Review

Find out if you qualify for compensation and learn your next steps – no cost, no obligation, just expert legal guidance.

Disclaimer: By submitting the form above and checking the consent box, you agree to our conditions and privacy policy and permit Ethen Ostroff Law to contact you via text messages, phone calls. Standard message rates may apply.


What Is Tylenol?

Most people have taken Tylenol at some point to ease an ache or bring down a fever. It’s been around for decades, and the main ingredient, acetaminophen, is what does the work. People often reach for it because it’s easy to get and is usually seen as a safer choice than other pain medicines. Johnson & Johnson, through its subsidiary McNeil Consumer Healthcare, manufactures Tylenol products.

Tylenol is commonly used for everyday pain relief, including headaches, muscle aches, back pain, menstrual cramps, and mild arthritis, as well as for lowering a fever. Because of its long-standing reputation as safe when used correctly, it’s often recommended to pregnant women for managing common discomforts, including backaches, cramping, headaches, and fevers.

Autism and ADHD Linked to Taking Tylenol While Pregnant

Concerns about Tylenol use during pregnancy started after several studies spotted a similar trend: children exposed to acetaminophen before birth seemed to be diagnosed with autism or ADHD more often than other kids.

Some of the most-cited research are:

  • American Journal of Epidemiology (2018): This study looked at over 130,000 mothers and their children. It found a higher rate of autism diagnoses in kids whose mothers took acetaminophen while pregnant.
  • JAMA Pediatrics (2019): Johns Hopkins researchers tested acetaminophen levels in umbilical cord blood. Babies with the highest levels were two to three times more likely to later be diagnosed with autism or ADHD.
  • International Journal of Epidemiology (2016): A Spanish birth cohort study found more autism-related traits in boys and more ADHD symptoms in kids whose mothers used acetaminophen during pregnancy.
  • European Journal of Epidemiology (2013): Data from Denmark showed a link between prenatal acetaminophen use and a higher chance of an ADHD diagnosis.
  • Nature Reviews Endocrinology (2021): Ninety-one scientists issued a statement urging pregnant women to be cautious with acetaminophen until more is known about the potential risks.

These findings are a big part of the Tylenol autism lawsuit and Tylenol ADHD lawsuit claims, as families argue they were never warned about the possible connection.

Autism and ADHD Linked to Taking Tylenol While Pregnant

Concerns about Tylenol use during pregnancy started after several studies spotted a similar trend: children exposed to acetaminophen before birth seemed to be diagnosed with autism or ADHD more often than other kids.

Some of the most-cited research:

  • American Journal of Epidemiology (2018): This study looked at over 130,000 mothers and their children. It found a higher rate of autism diagnoses in kids whose mothers took acetaminophen while pregnant.
  • JAMA Pediatrics (2019): Johns Hopkins researchers tested acetaminophen levels in umbilical cord blood. Babies with the highest levels were two to three times more likely to later be diagnosed with autism or ADHD.
  • International Journal of Epidemiology (2016): A Spanish birth cohort study found more autism-related traits in boys and more ADHD symptoms in kids whose mothers used acetaminophen during pregnancy.
  • European Journal of Epidemiology (2013): Data from Denmark showed a link between prenatal acetaminophen use and a higher chance of an ADHD diagnosis.
  • Nature Reviews Endocrinology (2021): Ninety-one scientists issued a statement urging pregnant women to be cautious with acetaminophen until more is known about the potential risks.

These findings are a big part of the Tylenol autism lawsuit and Tylenol ADHD lawsuit claims, as families argue they were never warned about the possible connection.

New 2025 Study Strengthens the Link

The evidence gained significant weight in August 2025. Researchers at Mount Sinai published a major analysis that reviewed 46 existing studies. Their conclusion reinforced the potential risk, linking prenatal Tylenol exposure to neurodevelopmental disorders. They suggest the drug crosses the placenta and may disrupt fetal brain development. This latest research provides some of the strongest support yet for the lawsuits, putting more pressure on the need for updated safety guidelines.

What Is Autism?

Autism spectrum disorder (ASD) is a developmental condition that affects how someone communicates, interacts, and experiences the world. It’s called a “spectrum” because it looks different for everyone. Some need daily help; others are mostly independent.

Signs often include:

  • Trouble sharing or reading emotions. 
  • Challenges with conversations, eye contact, or understanding jokes. 
  • Repeating movements, sticking to routines, or focusing intensely on certain topics. 
  • Sensitivity to lights, sounds, or textures.

Signs appear early or later in childhood. Early support, like speech or occupational therapy, can help kids manage daily life better.

What Is ADHD?

ADHD, or attention-deficit/hyperactivity disorder, affects focus, energy, and impulse control. It usually shows up in childhood but can be noticed later.

Common traits:

  • Easily distracted, trouble following instructions. 
  • Constant movement, fidgeting, or talking a lot. 
  • Acting or speaking before thinking, difficulty waiting.

These behaviors show up in school, at home, and later at work. Therapy, routines, and sometimes medication can help make daily life more manageable.

Other Health Concerns Linked to Tylenol Use in Pregnancy

Most of the attention around Tylenol during pregnancy is about autism and ADHD, but researchers are also looking at other possible risks. The findings aren’t consistent, and nothing is confirmed, but here’s what’s being studied:

  • Slower motor skills or emotional development, especially with late-pregnancy use 
  • Possible link to cerebral palsy, though evidence is limited 
  • Sleep problems, communication delays, or behavior challenges like aggression 
  • Hormonal changes that could affect development, still under study

MDL 3043, In Re: Acetaminophen – ASD/ADHD Products Liability Litigation

The Tylenol autism and ADHD lawsuits are grouped in MDL 3043. It’s officially named, “In re: Acetaminophen – ASD/ADHD Products Liability Litigation,” in New York. It started in October 2022 to handle federal cases claiming acetaminophen use during pregnancy may increase the risk of autism or ADHD in children. In 2023, Judge Denise L. Cote ruled that the plaintiffs’ main scientific experts couldn’t testify, and in August 2024 she dismissed the federal cases. The families appealed, and as of October 2025, the Second Circuit Court of Appeals has not made a decision.

Some claims about failure to warn and negligence are still moving forward. New expert reports have been submitted, and hearings are scheduled for early 2026. The MDL includes over 500 cases against Johnson & Johnson, Walmart, and other retailers. Defendants claim there’s no proven link between Tylenol and neurodevelopmental disorders and point to its long history of safe use. How the appeals and ongoing evidence play out will decide whether the federal case continues, or if families take claims to state courts or pursue settlements.

Companies Named in the Tylenol Autism and ADHD Lawsuits

The Tylenol autism and ADHD lawsuits are going after the maker of Tylenol and other big retailers that sold their own store-brand versions, which were often marketed as safe for pregnant women.

Some of the companies named in these lawsuits are:

  • Johnson & Johnson 
  • Costco Wholesale 
  • CVS Pharmacy 
  • Dollar Tree 
  • Family Dollar 
  • Rite Aid 
  • Safeway 
  • Target 
  • Walgreens 
  • Walmart 
  • 7-Eleven

These companies are accused of selling acetaminophen without warning pregnant women about studies showing possible links to autism and ADHD in children.

What the Tylenol Lawsuits Are Claiming

Parents filing these lawsuits say companies that make and sell Tylenol didn’t do enough to warn pregnant women about potential risks. Most of their claims focus on a few main points:

  • Companies should have added warnings once studies linked acetaminophen to autism and ADHD (failure to warn) 
  • Selling and promoting the products without giving the full picture was careless (negligence) 
  • Tylenol was unsafe because the labels didn’t include warnings, even if harm wasn’t intended (strict product liability) 
  • Promoting Tylenol as safe for pregnancy despite early research raising questions (fraud or misrepresentation)

These claims are part of MDL 3043, along with individual state cases. Families are seeking help with the costs of caring for their children and want the companies held accountable for not sharing the risks sooner.

Tylenol Autism Lawsuit Update 2025

The legal fight over Tylenol is at a critical point. While federal lawsuits have been stalled since a major dismissal in 2024, two powerful new developments in late 2025 have suddenly changed the landscape, giving families a new shot at justice.

The heart of the battle has always been the science. The federal cases were dismissed because Judge Denise L. Cote ruled the families’ evidence wasn’t strong enough. But now, with President Donald Trump’s warning and the FDA moving to update Tylenol’s label, the appeals court is under pressure to reconsider that decision.

Timeline of Key Events

  • September 2025: President Trump announces the FDA will warn doctors that Tylenol used during pregnancy might be linked to autism and ADHD in children. The FDA begins updating the medicine’s official label. A federal appeals court is set to hear a case next month that could reopen all the lawsuits. 
  • August 2025: Researchers at the Icahn School of Medicine at Mount Sinai publish a study finding that taking Tylenol during pregnancy may raise the risk of a child developing autism or ADHD, providing potential new evidence for the lawsuits. 
  • July 2025: Judge Cote grants summary judgment to the defendants. The plaintiffs file an appeal to revive the cases. 
  • April 2025: The appeals court has not yet issued a ruling. Attorneys continue to file new lawsuits in anticipation of a decision. 
  • December 2024: Legal experts predict the appeal decision will not come until 2025. Families continue filing lawsuits in state courts as the federal case remains on hold. 
  • September 2024: Families officially appeal Judge Cote’s ruling to the Second Circuit Court of Appeals. 
  • August 2024: Judge Cote dismisses the bulk of the federal lawsuits, ruling the plaintiffs’ experts did not provide sufficient scientific evidence to proceed. 
  • July 2024: The MDL remains active as Judge Cote considers whether to exclude testimony from a key plaintiffs’ expert, Dr. Roberta Ness. 
  • May 2024: A split emerges as some plaintiffs appeal dismissals while others proceed with Dr. Ness’s testimony. Defendants file motions to block her testimony. 
  • March 2024: Judge Cote allows some newer cases to proceed using Dr. Ness’s testimony. 
  • February 2024: Nearly all remaining MDL claims are dismissed. Plaintiffs prepare to appeal. 
  • December 2023: Judge Cote rules the plaintiffs’ experts cannot testify that Tylenol causes autism, citing a lack of scientific support. This signals a likely end to the MDL unless appeals succeed. 
  • June 2023: Additional retailers, including 7-Eleven and Dollar Tree, are added as defendants. 
  • May 2023: Approximately 118 Tylenol-related cases are active in federal court. 
  • April 2023: Judge Cote denies Johnson & Johnson’s motion to dismiss, allowing cases to move forward. 
  • January 2023: A discovery plan is put in place and a Special Master is appointed to manage plaintiff data. 
  • November 2022: Judge Cote approves the Retailer Liaison Committee and denies Walmart’s motion to dismiss. 
  • October 2022: The Tylenol lawsuits are officially consolidated into a single federal proceeding (MDL 3043) in the Southern District of New York, overseen by Judge Cote.

While the federal MDL is on hold, families continue to pursue claims in state courts. The future of the federal litigation now rests entirely on the upcoming decision from the appeals court.

Filing a Tylenol Lawsuit

If your child has autism or ADHD and you took Tylenol during pregnancy, you may have a case. Here’s how the process typically works:

  • Talk to a lawyer for a free consultation. They’ll go over your situation and let you know if you qualify. 
  • Gather documents with your lawyer’s help, like proof of Tylenol purchases, your child’s medical records, and other relevant history. 
  • File your claim. Your attorney handles all the paperwork and makes sure everything is submitted on time. 
  • Seek compensation. Most cases settle. However, your lawyer can take the case to court if the companies don’t agree.

Your legal team manages all aspects of your case throughout the process, so you could focus on your family’s needs.

Who Can File a Tylenol Autism Lawsuit or Tylenol ADHD Lawsuit?

Not every parent will qualify to file a Tylenol autism lawsuit, but many do. The main question is whether there’s a connection between using Tylenol (or generic acetaminophen) during pregnancy and your child’s diagnosis.

In most cases, you may be eligible if:

  • You took Tylenol or generic acetaminophen regularly while pregnant, most often in the second or third trimester. Using it just once or twice usually doesn’t meet the criteria. 
  • Your child has been diagnosed with autism or ADHD. The diagnosis must be confirmed by a doctor and documented in medical records. 
  • Your child is still under 18 years old.

If you’re unsure whether you qualify, a lawyer can review your case and help figure it out.

Compensation You Could Get from a Tylenol Case

Raising a child with autism or ADHD can get expensive, and families usually cover most of it themselves. If an ADHD or autism Tylenol lawsuit succeeds, it could help pay for:

  • Doctor visits, therapies, and medications 
  • Lost income from time off work or future earning challenges 
  • Special education, in-home support, or tools that make daily life easier 
  • The emotional stress on your child and family

The goal is to ease some of the financial burden and make the companies responsible for not warning families about the risks.

Deadline to File a Tylenol Case

Deadlines vary by state, but most give about two years. The clock usually starts when your child is diagnosed or when you first learn Tylenol might be involved. If you’re unsure, talk to a Tylenol lawsuit lawyer soon so you don’t miss your chance.

Thinking About a Tylenol Autism/ADHD Lawsuit?

If you took Tylenol while pregnant and your child was later diagnosed with autism or ADHD, you’ve probably seen the headlines about these lawsuits. A lot of families trusted Tylenol for years, not knowing studies would later raise questions about its safety during pregnancy.

While EOL.Law isn’t taking new Tylenol autism cases at this time, we put this information together so parents can better understand what’s happening with the litigation and what options might be out there. If you think you might have a claim, talk with a lawyer who’s handling Tylenol cases as soon as you can.

Frequently Asked Questions

No, the lawsuit isn’t completely over, but it hit a major roadblock. A federal judge dismissed the main case because she didn’t believe the science presented was strong enough to prove the link. While families have appealed that decision, the real action has now moved to state courts, where some cases are still moving forward.

Research suggests genetics and family history play the largest role. While some studies noticed a possible connection with Tylenol, the most thorough research that compared siblings found no direct cause. Most doctors still consider Tylenol relatively safe when truly needed during pregnancy, though they recommend using the lowest dose for the shortest time.

Generally, you’d need to show you took Tylenol regularly during pregnancy, with medical records or receipts to support this. The child would need a formal autism or ADHD diagnosis from a healthcare provider. Since federal cases are paused, your best move is to consult with a lawyer who handles these lawsuits to see if you qualify under your state’s laws.

There isn’t a traditional Tylenol class action lawsuit for autism or ADHD claims. Instead, the cases, including Tylenol lawsuit ADHD claims, are grouped together in federal court as MDL 3043. This makes it easier to handle hundreds of individual lawsuits against Johnson & Johnson and major retailers while keeping the focus on the claims.

Since autism largely develops from genetic factors, there’s no guaranteed prevention. However, doctors recommend general healthy practices: avoid smoking and alcohol, manage conditions like diabetes, and take prescribed prenatal vitamins. While some choose to limit Tylenol, it’s still considered safer than alternatives like ibuprofen for managing significant pain or fever during pregnancy.

Success

We received your information. We’ll be in touch soon.

While in law school, he distinguished himself as Executive Editor of JURIS Magazine, received the prestigious CALI Excellence for the Future Award, and completed five hands-on internships that laid a strong foundation for his legal career.


Nicholas began his post-graduate career clerking for the Honorable Linda Rovder Fleming in the Cambria County Court of Common Pleas. From there, he quickly found his calling in workers’ compensation, personal injury, and Social Security disability law—areas where he could directly impact people’s lives in moments of crisis. He’s helped clients navigate complex legal claims, including securing a settlement exceeding $300,000.

Nicholas brings clear communication, genuine empathy, and an unrelenting drive to achieve the best outcomes for his clients. Whether he’s navigating a complex workers’ comp claim or pushing for a major settlement, he brings focus, dedication, and deep legal knowledge to every case.

He’s also a proud member of Pennsylvania Advocates for Justice and remains active in various professional legal organizations. Nicholas is licensed to practice law in Pennsylvania.

When he’s not fighting for the injured, Nicholas is enjoying time with his family, kicking a soccer ball around, hitting the golf course, or cheering on Pittsburgh’s local teams.

Joe Ring heads the workers’ compensation department at Ethen Ostroff Law, where he takes pride in fighting for injured workers.

Joe is a Philadelphia native and maintains deep roots in the area.  As the grandson of a Philadelphia Firefighter, son of a Philadelphia public school teacher, and veteran of the United State Marine Corps, he was taught to value service, dedication, and hard work.   He applies these values to every case and takes great satisfaction in representing hard-working clients with those same traits.

After obtaining his bachelor’s degree in history from St. Vincent College in Western Pennsylvania, he graduated from Villanova Law School in 2012 and, since then, has litigated hundreds of workers’ compensation hearings and trial depositions on behalf of both employers and injured workers.  During this time, Mr. Ring has written articles and presented Continuing Legal Education courses on developments in Pennsylvania Workers’ Compensation Law.  He is active in local professional organizations, and, in 2022, he served a Co-chairperson of the Philadelphia Bar Associations Workers’ Compensation Section.

Since coming to EOL in 2024, he has dedicated his practice entirely to helping injured workers navigate the system and obtain their rightful benefits.

Joe is licensed to practice in Pennsylvania.

Brandon Zanan heads the personal injury claim department with Ethen Ostroff Law.

Brandon’s education in both law and medicine assist him in expertly representing badly injured victims. Brandon has a Master’s Degree in Forensic Medicine from the Philadelphia College of Osteopathic Medicine, with a concentration in anatomy and pathology. With this knowledge,  Brandon is skilled at analyzing medical records and understanding injuries that are common in personal injury claims. He uses this expertise in conjunction with listening carefully to each client’s needs, in order to fiercely advocate for clients and tell their stories when they would not otherwise have a voice.

Brandon’s background includes a variety of experience and skills in various areas of civil practice. He is the author and editor of numerous books for the George T. Bisel Publishing Company, including “Pennsylvania Damages” and the “Pennsylvania Vehicle Code Annotated,” two texts that are frequently relied on by lawyers and judges across Pennsylvania as authoritative resources on personal injury law.

Brandon is a member of the Pennsylvania and Montgomery Bar Associations. He is also a member of Pennsylvania Association for Justice, and has served as an executive board member of the Montgomery American Inn of Court.

He is admitted to practice in the Commonwealth of Pennsylvania, the United States District Courts for the Eastern District of Pennsylvania and Middle District of Pennsylvania, the State of New Jersey, the United States District Court for the District of New Jersey, and in the Commonwealth of Virginia. Brandon has represented many clients in motor vehicle, premises liability, animal bite, and products liability cases across Pennsylvania and New Jersey and has obtained outstanding results with millions of dollars recovered for his clients.

He has been named a Pennsylvania Rising Star from 2021 onward. The “Super Lawyers-Rising Star®”, list recognizes no more than 2.5 percent of attorneys in each state

Brandon currently lives in Malvern with his wife Rachel and their son Max.

Ethen Ostroff Law, PLLC Terms and Conditions

Effective Date: July 10, 2024

General Information

Welcome to the website of Ethen Ostroff Law, PLLC (“EO”). By accessing or using our website, you agree to be bound by these Terms and Conditions (“Terms”). If you do not agree with these Terms, please do not use our website.

Use

EO hereby grants you a non-exclusive, non-transferable, revocable, limited right and license to access and use the Site solely for your personal use in accordance with these Terms of Use. You shall not, in any way, otherwise copy, reproduce, distribute, transmit, display, perform, reproduce, publish, license, modify, create derivative works from, sell, or exploit the Site.

EO may at any time, for any reason, and without notice or liability: (a) modify, suspend, or terminate operation of or access to the Site and related services, or (b) change, revise, or modify the Site and affiliated services.

Messaging and Automated Calls

When you opt-in, you will receive text messages (SMS/MMS) on your mobile number. These messages may contain information about your case, and the message frequency may vary from user to user. Please note that message and data rates may apply. If you wish to opt out of this service, you can do so anytime by simply texting “STOP” to the phone number. Once you text “STOP” to us, we will send you an SMS to confirm that you have been unsubscribed. If you encounter any issues, you can reply with the keyword “HELP” to get assistance. Please be aware that carriers are not responsible for any delayed or undelivered messages.

By providing your phone number and submitting a form on our website, you consent to receive communications, including automated calls, texts, and pre-recorded messages, from EO and its affiliates. These communications may include updates about your case, promotional offers, and other information. You understand that these calls may be generated using automated technology, and that standard message and data rates may apply.

Your consent to receive automated calls is not a condition of any purchase or service. By checking the consent box on our contact form or by calling our firm, you agree to these Terms and Conditions and provide your written consent to receive these communications. You may opt out of these communications at any time by replying STOP to any text message or by contacting us at [insert contact information].

State-Specific Compliance

EO complies with all federal and state laws regarding automated calls and telemarketing practices. Certain states have additional restrictions on the use of automated dialing systems and pre-recorded messages. The following states have more restrictive regulations:

  • California: Requires prior express written consent for automated calls.
  • Florida: Requires prior express written consent for automated calls and texts.
  • New York: Requires prior express written consent for automated calls.
  • Texas: Requires prior express written consent for automated calls.

If you are a resident of one of these states, EO will obtain your prior express written consent before making any automated calls or sending pre-recorded messages to you.

By submitting a form inquiry or calling our firm, you agree to us contacting you, and your checking the box when submitting your form inquiry serves as written consent.

Information and Legal Disclaimer

The information contained in this website is for informational purposes only, and should not be construed as legal advice. Testimonials and case results contained in this website are for demonstrative purposes only, and do not constitute a guarantee of any particular outcome in a specific case.

By requesting a free consultation with Ethen Ostroff Law, PLLC, you agree to the following:

  • Any information I submit is for review only, and there will be no charge for the initial consultation.
  • I have not entered into an attorney-client relationship with Ethen Ostroff Law, PLLC until such time as a formal written Retainer Agreement is signed by myself and a representative of Ethen Ostroff Law, PLLC. There is no guarantee that Ethen Ostroff Law, PLLC will accept my case.
  • Any information received by Ethen Ostroff Law, PLLC, prior to the execution of a written Retainer Agreement, is not subject to the Attorney-Client Privilege and is not considered confidential.
  • Additional information may be requested in order for Ethen Ostroff Law, PLLC to make a decision on whether or not to accept my case.
  • Because no attorney-client relationship has been established, I will remain personally responsible to meet all necessary deadlines applicable to my claim, until such time as Ethen Ostroff Law, PLLC makes a final decision. I acknowledge that I have not received any representations or legal opinions with respect to any time frames or deadlines that may be applicable to my claim.

No Relationship or Obligation Arises from Use of the Site

The law differs in every jurisdiction, and you should not rely on any opinion except that of an attorney you have retained, who has a professional duty to advise you after being fully informed of all the pertinent facts, and who is licensed in the applicable state, and is familiar with the applicable law. Internet subscribers, mobile application users, and online readers should seek professional counsel about their legal rights and remedies. You should not act or refrain from acting on the basis of any information found on the Site. Any actions or decisions about your legal rights should be based on the particular facts and circumstances of your situation, and appropriate legal advice from an attorney retained directly by you. EO EXPRESSLY DISCLAIMS ALL LIABILITY WITH RESPECT TO ACTIONS TAKEN OR NOT TAKEN BASED UPON ANY INFORMATION OR OTHER CONTENTS OF THIS SITE. Viewing the Site, or communicating with EO by Internet e-mail or through the Site does not constitute or create an attorney-client relationship with anyone. The content and features on the Site do not create, and are not intended to create, an attorney-client relationship, and shall not be construed as legal advice. The content and features of the Site, including means to submit a question or information, do not constitute an offer to represent you or otherwise give rise to an attorney/client relationship.

THE SITE IS PROVIDED “AS IS”. EO MAKES NO WARRANTIES, EXPRESS OR IMPLIED, REGARDING THE SITE AND ONLINE SERVICES AND HEREBY DISCLAIMS ALL WARRANTIES OF ANY KIND OR NATURE, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT. WITHOUT LIMITING THE FOREGOING, EO DOES NOT GUARANTEE THAT THE ONLINE SERVICES OR PRODUCTS WILL MEET YOUR REQUIREMENTS, OR WILL BE ERROR-FREE, UNINTERRUPTED, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS, OR THAT ANY DEFECTS WILL BE CORRECTED.

Accounts

To use some features of the Site, you may be required to create an account. In connection therewith, you agree to provide and maintain true, accurate, current, and complete information about yourself. You are responsible for maintaining the confidentiality of the information you hold for your account login, including your password, and for all Submissions made from your account. You agree to notify us immediately of any unauthorized use of your login. EO may suspend access to your account if it suspects illegal or improper use, or for other reasons, such as for account management purposes, at its sole discretion.

Confidentiality is Not Guaranteed

Information sent to Ethen Ostroff Law, PLLC. via Internet e-mail or through the Site is not secure and is done on a non-confidential basis. EO may make reasonable efforts to keep communications private, but because of the nature of Internet communications and the absence of an attorney/client relationship, we cannot promise or guarantee confidentiality.

DISCLAIMER – This Site Does Not Provide Medical Diagnosis or Advice

The content provided on the Site, such as documents, text, graphics, images, videos, news alerts, pharmaceutical drug recalls, prescription medication history, or information on litigation concerning the foregoing topics, or other materials, is for informational purposes only. The information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult a physician for diagnosis and treatment of any medical condition or for any questions you may have regarding a health concern. Never disregard professional medical advice, alter a prescription plan in any way, or delay or refrain from seeking medical advice because of something you have read or seen on the Site. Links to other sites are provided for information only. Use of trade names is for identification only and does not constitute endorsement by EO.

Without limiting the generality of the foregoing, the Site may present information about pharmaceutical drug recalls, which is for information purposes only. Such information is not necessarily the most current information on the subject and may or may not be updated based on the last information concerning such recalls. Do not make any decisions regarding medication or medical providers based on information from the Site, including but not limited to information we provide about drug recalls.

EO Is Not Responsible for Content; Limitation on Liability

EO may periodically change, remove, or add the material on the Site without notice. This material may contain technical or typographical errors. EO DOES NOT GUARANTEE ITS ACCURACY, COMPLETENESS OR SUITABILITY. EO assumes no liability or responsibility for any errors or omissions in the contents of the Site. Your use of the Site is at your own risk. Under no circumstances shall EO or any other party involved in the creation, production, or delivery of the Site be liable to you or any other person for any indirect, special, incidental, or consequential damages of any kind arising from your access to, or use of, the Site. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW IN NO EVENT SHALL EO BE LIABLE FOR ANY SPECIAL, INDIRECT, OR CONSEQUENTIAL DAMAGES RELATING TO THIS MATERIAL, FOR ANY USE OF THIS WEBSITE, OR FOR ANY OTHER LINKED WEBSITE.

Third-party Web Sites

The Site contains links to third-party websites for the convenience of our users. EO does not endorse any of these third-party sites and does not imply any association between EO and those sites. EO does not control these third-party websites and cannot represent that their policies and practices will be consistent with these Terms of Use. If you use links to access and use such websites, you do so at your own risk. EO is not responsible for the contents or availability of any linked sites. These links are provided only as a convenience to the recipient. These Terms only apply to the Site and do not apply to any linked sites. We encourage you to read and understand the terms of use of any linked sites that you visit. Links do not imply that we sponsor, endorse, are affiliated with or associated with, or are legally authorized to use any trademark, trade name, service mark, design, logo, symbol, or other copyrighted materials displayed on or accessible through any linked site.

EO Clients

Only individuals who have entered into a mutually signed retainer agreement with EO are EO clients (“EO Clients”).

Legal and Ethical Requirements

EO has tried to comply with all legal and ethical requirements in compiling the Site. We welcome comments about our compliance with the applicable rules and will update the Site as warranted, upon learning of any new or different requirements.

Ethen Ostroff Law reserves the right to refer or sell leads that come through any of Ethen Ostroff Law’s marketing.

Ethen Ostroff Law also may sell leads on certain campaigns generated in association with third party marketing companies.

Governing Laws in Case of Dispute; Jurisdiction

These Terms of Use shall be governed by and construed in accordance with the laws of the State of Pennsylvania, USA, without regard to any choice of law principles. Any and all disputes arising hereunder shall be governed as set forth in the Arbitration section below.

Submissions

You are solely responsible for any information, content, or material you transmit to or through the Site (“Submissions”). You understand that Submissions are considered non-confidential and non-proprietary. Furthermore, you grant EO an unrestricted, irrevocable, perpetual, transferable, sublicensable, worldwide, royalty-free license to use, copy, reproduce, display, publish, publicly perform, transmit, and distribute any Submission, without compensation or accounting to you or anyone else. You represent and warrant that: (a) you have the right to submit the Submission to EO and grant the licenses as described above; (b) EO will not need to obtain licenses from any third party or pay royalties to any third party for its use of the Submission; (c) the Submission does not infringe any third party’s rights, including intellectual property rights and privacy rights; and (d) the Submission complies with these Terms of Use and all applicable laws and regulations.

EO takes no responsibility and assumes no liability for any Submission.

Arbitration

Any and all claims by you arising out of or related to the Site or your use thereof may be resolved only through a binding arbitration proceeding to be conducted under the auspices of the Commercial Arbitration Rules of the American Arbitration Association in Montgomery County, Pennsylvania. Both your agreement to arbitrate all controversies, disputes and claims, and the results and awards rendered through the arbitration, will be final and binding on you and may be specifically enforced by legal proceedings. Arbitration will be the sole means of resolving such controversies, disputes and claims, and you waive your rights to resolve such controversies, disputes and claims by court proceedings or any other means. You agree that judgment may be entered on the award in any court of competent jurisdiction and, therefore, any award rendered shall be binding. The arbitrator may not consolidate more than one person’s claims, and may not otherwise preside over any form of a representative or class proceeding. You understand that by agreeing to arbitration as a mechanism to resolve all controversies, disputes and claims between us, you are waiving certain rights, including the right to bring an action in court, the right to a jury trial, the right to broad discovery, and the right to an appeal. You understand that in the context of arbitration, a case is decided by an arbitrator (one or more), not by a judge or a jury.

International Use

The Site is controlled, operated, and administered by EO from offices within the United States of America and is only intended for use therein. We make no representation regarding use of the Site outside of the United States.

Other Terms

If, for any reason, our Terms of Use, Privacy Policy, or any portion thereof to be unenforceable, such provision shall be enforced to the maximum extent permissible so as to give the intended effect thereof, and the remainder of these Terms of Use and Privacy Policy shall continue in full force and effect. EO’s failure to act with respect to a breach by you or others does not waive our right to act with respect to that breach or subsequent or similar breaches. No consent or waiver by EO hereof will be deemed effective unless in writing. These Terms of Use, together with our Privacy Policy, as each is currently posted, constitute the entire agreement between EO and you with respect to your use of the Site and supersede all previous written or oral agreements relating to the subject matter hereof, that this agreement shall not supersede, restrict, or replace any agreements governing the attorney-client relationship between EO and EO Clients.

EO may, in its sole discretion and without prior notice, block and/or terminate your access to the Site and if we determine that you have violated these Terms of Use or other terms or agreements or that may be associated therewith or if you use the Site in a way that we deem, in our sole discretion, to be an unacceptable use.